Global Intravenous Infusion Pumps Market Size, Share, and COVID-19 Impact Analysis, By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps, and Others), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Pediatrics/Neonatology, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Intravenous Infusion Pumps Market Size Forecasts to 2035

• The Global Intravenous Infusion Pumps Market Size Was Estimated at USD 6.07 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.41% from 2025 to 2035
• The Worldwide Intravenous Infusion Pumps Market Size is Expected to Reach USD 14.75 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

The global intravenous infusion pumps market size was worth around USD 6.07 billion in 2024 and is predicted to grow to around USD 14.75 billion by 2035 with a compound annual growth rate (CAGR) of 8.41% from 2025 to 2035. The growing prevalence of chronic diseases, an aging global population, and technological advancements are primarily driving the intravenous infusion pumps market globally.

Market Overview

The intravenous infusion pumps market refers to the market of medical devices that deliver fluids, medications, or nutrients into a patient’s body in a controlled and precise manner. Intravenous infusion pumps are widely used in hospitals, clinics, and other healthcare settings for administering IV infusions. The demand for IV infusion pumps is driven by the increasing incidence of diseases like diabetes, cancer, and heart-related issues due to the need for administering medication through IV infusion pumps. The emergence of ambulatory infusion pumps is driven by the preference for home healthcare to facilitate secure and efficient treatment away from home. Further, these pumps are incorporated with advanced features like intelligent pumps, wireless connectivity, and monitoring systems for improving patient safety, treatment precision, and remote monitoring. Growing awareness, improvement in healthcare systems, increasing per capita income & healthcare expenditure for advanced healthcare treatments are several factors that are creating market growth opportunities.

Report Coverage

This research report categorizes the intravenous infusion pumps market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the intravenous infusion pumps market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the intravenous infusion pumps market.

Driving Factors

The growing demand for intravenous infusion pumps due to the rising prevalence of chronic diseases is propelling the intravenous infusion pumps market. Further, an increasing use of intravenous infusion pumps among the aging population, owing to their need, especially in home healthcare settings, is driving the market demand. IV infusion therapy is needed for safe and effective treatments for conditions such as diabetes, cardiovascular disease, and cancer, with the growing elderly population. Technology advancements, including the emergence of smart infusion technology that potentially reduces errors such as incorrect dose, rate, and pump failure, are contributing to driving the market growth.

Restraining Factors

The increased cost of devices, product recalls, and challenges in the healthcare workforce are several factors that are restraining the market. Further, the limited healthcare budgets and stringent regulatory requirements due to safety concerns are hampering the market growth.

Market Segmentation

The intravenous infusion pumps market share is classified into product and disease indication.

• The volumetric infusion pumps segment dominated the market with a significant share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product, the intravenous infusion pumps market is divided into volumetric infusion pumps, syringe infusion pumps, and others. Among these, the volumetric infusion pumps segment dominated the market with a significant share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Volumetric infusion pumps include the use of a motorized mechanism for delivering fluids from an IV bag or container through an administration set and into the patient’s vein. The efficiency of volumetric infusion pumps in the precise delivery of large volumes for managing chronic diseases like cancer and diabetes, as well as for surgical procedures, is driving the market.

• The pediatrics/neonatology segment dominated the market with a significant revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the disease indication, the intravenous infusion pumps market is divided into chemotherapy, diabetes, gastroenterology, pediatrics/neonatology, and others. Among  these, the pediatrics/neonatology segment dominated the market with a significant revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Infusion pumps precisely and safely deliver fluids and medication to newborns and children. Advanced infusion pumps for accurate medication delivery and for reducing overdose risks are propelling the market growth in the paediatrics/ neonatology segment.

Regional Segment Analysis of the Intravenous Infusion Pumps Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the intravenous infusion pumps market over the predicted timeframe.

North America is anticipated to hold the largest share of the Intravenous Infusion Pumps market over the predicted timeframe. The growing number of surgical procedures performed, along with the adoption of advanced technology in infusion pumps, are driving the market. The increasing need for precise and customizable drug delivery systems and advancements in infusion pump technology are contributing to the market growth.  

Asia Pacific is expected to grow at a rapid CAGR in the intravenous infusion pumps market during the forecast period. The region’s growing prevalence of chronic diseases and the geriatric population are responsible for driving the market demand for intravenous infusion pumps. Further, the introduction of ambulatory infusion pumps and the adoption of refurbished & rental infusion pumps are escalating the market of intravenous infusion pumps.  

Europe is anticipated to hold a significant share of the intravenous infusion pumps market during the projected timeframe. The increasing prevalence of chronic diseases and demand for ambulatory infusion pumps in home care settings are driving the intravenous infusion pumps market. Further, the presence of well-developed healthcare infrastructure and the adoption of advanced patient care technologies are propelling the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the intravenous infusion pumps market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Baxter
• B. Braun Medical Inc.
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• Cardinal Health
• Fresenius Kabi AG
• ICU Medical, Inc.
• F. Hoffmann-La Roche Ltd
• Tandem Diabetes Care, Inc.
• Terumo Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Moog Inc.
• IRadimed Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In April 2025, ICU Medical Inc., a worldwide leader in the development, manufacture, and sale of innovative medical devices, announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo.
• In November 2024, Boston Scientific Corporation announced it had entered into a definitive agreement to acquire Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 hepatic artery infusion (HAI) pump and the chemotherapy drug floxuridine, which are approved by the FDA.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the intravenous infusion pumps market based on the below-mentioned segments: 

Global Intravenous Infusion Pumps Market, By Product

• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Others

Global Intravenous Infusion Pumps Market, By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Pediatrics/Neonatology
• Others

Global Intravenous Infusion Pumps Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa